These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. [Plasma homocysteine levels in patients with ischemic heart disease]. Márk L; Erdei F; Márki-Zay J; Nagy E; Kondacs A; Katona A Orv Hetil; 2001 Jul; 142(30):1611-5. PubMed ID: 11519232 [TBL] [Abstract][Full Text] [Related]
4. The role of vitamin B12 in fasting hyperhomocysteinemia and its interaction with the homozygous C677T mutation of the methylenetetrahydrofolate reductase (MTHFR) gene. A case-control study of patients with early-onset thrombotic events. D'Angelo A; Coppola A; Madonna P; Fermo I; Pagano A; Mazzola G; Galli L; Cerbone AM Thromb Haemost; 2000 Apr; 83(4):563-70. PubMed ID: 10780318 [TBL] [Abstract][Full Text] [Related]
5. The C677T mutation in methylenetetrahydrofolate reductase gene, plasma homocysteine concentration and the risk of coronary artery disease. Kadziela J; Janas J; Dzielińska Z; Szperl M; Gaździk D; Chotkowska E; Piotrowski W; Ruzyłło W Kardiol Pol; 2003 Jul; 59(7):17-26; discussion 26. PubMed ID: 14560345 [TBL] [Abstract][Full Text] [Related]
6. [Some aspects of homocysteine metabolism in hemodialysis patients]. Bednarek-Skublewska A; Buraczyńska M; Wawrzycki S; Baranowicz-Gaszczyk I; Ksiazek A Pol Arch Med Wewn; 2002 Nov; 108(5):1041-7. PubMed ID: 12685244 [TBL] [Abstract][Full Text] [Related]
7. Comparative study of response to treatment with supraphysiologic doses of B-vitamins in hyperhomocysteinemic hemodialysis patients. Nakhoul F; Abassi Z; Plawner M; Khankin E; Ramadan R; Lanir N; Brenner B; Green J Isr Med Assoc J; 2004 Apr; 6(4):213-7. PubMed ID: 15115259 [TBL] [Abstract][Full Text] [Related]
8. Methylenetetrahydrofolate reductase genotype, vitamin B12, and folate influence plasma homocysteine in hemodialysis patients. Nakamura T; Saionji K; Hiejima Y; Hirayama H; Tago K; Takano H; Tajiri M; Hayashi K; Kawabata M; Funamizu M; Makita Y; Hata A Am J Kidney Dis; 2002 May; 39(5):1032-9. PubMed ID: 11979347 [TBL] [Abstract][Full Text] [Related]
9. Methylenetetrahydrofolate reductase gene C677T polymorphism, homocysteine, vitamin B12, and DNA damage in coronary artery disease. Andreassi MG; Botto N; Cocci F; Battaglia D; Antonioli E; Masetti S; Manfredi S; Colombo MG; Biagini A; Clerico A Hum Genet; 2003 Feb; 112(2):171-7. PubMed ID: 12522558 [TBL] [Abstract][Full Text] [Related]
10. No effect of homocysteine-lowering therapy on vascular inflammation and haemostasis in peripheral arterial occlusive disease. Schernthaner GH; Plank C; Minar E; Bieglmayer C; Koppensteiner R; Schernthaner G Eur J Clin Invest; 2006 May; 36(5):333-9. PubMed ID: 16634837 [TBL] [Abstract][Full Text] [Related]
11. The mutation Ala677-->Val in the methylene tetrahydrofolate reductase gene: a risk factor for arterial disease and venous thrombosis. Arruda VR; von Zuben PM; Chiaparini LC; Annichino-Bizzacchi JM; Costa FF Thromb Haemost; 1997 May; 77(5):818-21. PubMed ID: 9184384 [TBL] [Abstract][Full Text] [Related]
12. Effect of MTHFR 677C>T on plasma total homocysteine levels in renal graft recipients. Födinger M; Wölfl G; Fischer G; Rasoul-Rockenschaub S; Schmid R; Hörl WH; Sunder-Plassmann G Kidney Int; 1999 Mar; 55(3):1072-80. PubMed ID: 10027946 [TBL] [Abstract][Full Text] [Related]
13. Levels of lipoprotein and homocysteine in non-obese and obese patients with polycystic ovary syndrome. Yilmaz M; Biri A; Bukan N; Karakoç A; Sancak B; Törüner F; Paşaoğlu H Gynecol Endocrinol; 2005 May; 20(5):258-63. PubMed ID: 16019370 [TBL] [Abstract][Full Text] [Related]
14. Hyperhomocysteinemia in hemodialysis patients: effects of 12-month supplementation with hydrosoluble vitamins. Tremblay R; Bonnardeaux A; Geadah D; Busque L; Lebrun M; Ouimet D; Leblanc M Kidney Int; 2000 Aug; 58(2):851-8. PubMed ID: 10916110 [TBL] [Abstract][Full Text] [Related]
15. Homocysteine, methylenetetrahydrofolate reductase C677T polymorphism and the B-vitamins: a facet of nature-nurture interplay. Herrmann W; Obeid R; Schorr H; Zarzour W; Geisel J Clin Chem Lab Med; 2003 Apr; 41(4):547-53. PubMed ID: 12747601 [TBL] [Abstract][Full Text] [Related]
16. Association of methylenetetrahydrofolate (MTHFR) and apolipoprotein E (apo E) genotypes with homocysteine, vitamin and lipid levels in carotid stenosis. Zuntar I; Antoljak N; Vrkić N; Topić E; Kujundzić N; Demarin V; Vuković V Coll Antropol; 2006 Dec; 30(4):871-8. PubMed ID: 17243563 [TBL] [Abstract][Full Text] [Related]
17. Hyperhomocysteinemia and the methylenetetrahydrofolate reductase 677C-T mutation in patients under 50 years of age affected by central retinal vein occlusion. Di Crecchio L; Parodi MB; Sanguinetti G; Iacono P; Ravalico G Ophthalmology; 2004 May; 111(5):940-5. PubMed ID: 15121372 [TBL] [Abstract][Full Text] [Related]
18. Anti-epileptic drug treatment in children: hyperhomocysteinaemia, B-vitamins and the 677C-->T mutation of the methylenetetrahydrofolate reductase gene. Vilaseca MA; Monrós E; Artuch R; Colomé C; Farré C; Valls C; Cardo E; Pineda M Eur J Paediatr Neurol; 2000; 4(6):269-77. PubMed ID: 11277368 [TBL] [Abstract][Full Text] [Related]
20. The influence of age, sex, vitamin B(12), folate levels and methylenetetrahydrofolate reductase C677T genetic mutations on plasma homocysteine in the Chinese population. Ho CH Haematologica; 2000 Oct; 85(10):1051-4. PubMed ID: 11025596 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]